3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Head and Neck Neoplasms
4
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Thyroid Nodule
1
Spinal Cord Tumor of Cervical Spine
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Pathologic Complete Response
1
Parotid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Pulmonary Nodules
1
Mouth Neoplasms
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Trastuzumab
2
toripalimab
1
pyrotinib
1
Vinblastine
1
Transurethral Resection of Bladder
1
Thalidomide
1
TP protocol
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Metformin
1
Magnetic Resonance Imaging
1
Immunohistochemistry
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Cisplatin
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Carboplatin
1
Bortezomib
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pathologic Complete Response
×
Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled